These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2994227)

  • 21. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus.
    Dal Forno G; Pietra C; Urciuoli M; van Amsterdam FT; Toson G; Gaviraghi G; Trist D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor type for cholecystokinin on isolated intestinal muscle cells of the guinea pig.
    Morini G; Barocelli E; Impicciatore M; Grider JR; Makhlouf GM
    Regul Pept; 1990 May; 28(3):313-21. PubMed ID: 2377745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that cholecystokinin octapeptide (CCK-8) acts as a potent, full agonist on gastrin receptors for acid secretion in the isolated mouse stomach: lack of antagonism by the specific CCK antagonist asperlicin.
    Lotti VJ; Chang RS; Kling PJ; Cerino DJ
    Digestion; 1986; 35(3):170-4. PubMed ID: 3781112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and pharmacological profiles of loxiglumide, a novel cholecystokinin-A receptor antagonist.
    Fukamizu Y; Nakajima T; Kimura K; Kanda H; Fujii M; Saito T; Kasai H
    Arzneimittelforschung; 1998 Jan; 48(1):58-64. PubMed ID: 9522034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of receptor desensitization to analyse CCKA and CCKB/gastrin receptors coupled to contraction in guinea-pig stomach muscle.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1995 Jan; 114(2):339-48. PubMed ID: 7881733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological effects of newly synthesized cholecystokinin analogs.
    Verspohl EJ; LaMura M
    Horm Res; 2000; 53(4):177-84. PubMed ID: 11044801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder.
    Grider JR; Makhlouf GM
    Am J Physiol; 1990 Aug; 259(2 Pt 1):G184-90. PubMed ID: 2382717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin type B receptor antagonist PD-136,450 is a partial secretory agonist in the stomach and a full agonist in the pancreas of the rat.
    Schmassmann A; Garner A; Flogerzi B; Hasan MY; Sanner M; Varga L; Halter F
    Gut; 1994 Feb; 35(2):270-4. PubMed ID: 8307482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist.
    Yamazaki Y; Akahane M; Kobayashi M; Kitazawa M; Kurashina Y; Iizuka K
    Jpn J Pharmacol; 1993 Oct; 63(2):219-25. PubMed ID: 7506805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.
    van der Bent A; Blommaert AG; Melman CT; IJzerman AP; van Wijngaarden I; Soudijn W
    J Med Chem; 1992 Mar; 35(6):1042-9. PubMed ID: 1552499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the biosynthesis of asperlicin and the directed biosynthesis of analogs in Aspergillus alliaceus.
    Houck DR; Ondeyka J; Zink DL; Inamine E; Goetz MA; Hensens OD
    J Antibiot (Tokyo); 1988 Jul; 41(7):882-91. PubMed ID: 3417563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a new CCK antagonist, L364,718: in vitro and in vivo studies.
    Louie DS; Liang JP; Owyang C
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G261-6. PubMed ID: 2458681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a new and potent cholecystokinin antagonist on motor responses of the guinea-pig intestine.
    Barthó L; Holzer P; Lembeck F; Lippe IT; Setnikar I
    Br J Pharmacol; 1987 Apr; 90(4):753-61. PubMed ID: 3580706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA; Gerskowitch VP; Hull RA; Shankley NP; Black JW
    Br J Pharmacol; 1992 May; 106(1):61-6. PubMed ID: 1504732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.